TrialJournal for immunotherapy of cancer2021

Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.

Barbara Manzanares-Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.